Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 Biomarker disease BEFREE Three different interventions that prevented kidney growth and glomerular enlargement (calorie intake reduction, inhibition of mammalian target of rapamycin complex, and inhibition of angiotensin-converting enzyme) protected against FSGS lesion development, even when initiated late in the process. 28720684 2017
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE However, a link between ACE I/D gene polymorphism and FSGS risk was not found in Caucasians, Africans, Arabs or Jews (Caucasians: D: p = 0.11, DD: p = 0.19, II: p = 0.70; Africans: D: p = 0.40, DD: p = 0.49, II: p = 0.61; Arabs: D: p = 0.34, DD: p = 0.10, II: p = 0.42; Jews: D: p = 0.90, DD: p = 0.97, II: p = 0.83). 21652690 2011
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE To elucidate this issue, we investigated the relationship between the insertion (I) and deletion (D) ACE gene polymorphism and rapidity of progression of FSGS to ESRD in Iranian children. 19076285 2008
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease LHGDN Angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been studied as a predictor of clinical course in common multi-factorial diseases including focal segmental glomerulosclerosis. 16272677 2005
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE A role for ACE polymorphisms in the progression of FSGS has been found in some studies. 14730545 2004
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE There was no difference in the ACE I/D distribution between children with FSGS and normal controls (II 10%, ID 60%, DD 30% vs. II 13%, ID 70%, DD 17%). 14986085 2004
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. 12571380 2003
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS). 14610337 2003
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease LHGDN We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS). 14610337 2003
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes. 11474225 2001
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE Homozygosity for the ACE insertion allele may have a protective effect in children with FSGS and can serve as a positive prognostic indicator at diagnosis. 9853248 1998
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation disease BEFREE Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis. 9434071 1997